Lou Reese, Executive Chairman at Vaxxinity, Inc. (VAXX), bought 8,038 shares at $3.37 ($27K) on 2022-04-25, disclosed to the SEC on 2022-04-27.
Scheduled purchase ($27k) by Executive Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VAXX | BUY | 2022-04-28 | $142K | — | Filing → |
| VAXX | BUY | 2021-11-15 | $242K | — | Filing → |